Topics

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

13:49 EST 3 Feb 2020 | News-Medical.net

Calibr, the drug discovery and development division of Scripps Research, today announced that the U.S. Food and Drug Administration has given clearance to the Investigational New Drug (IND) application for Calibr's "switchable" CAR-T cell therapy, which is being evaluated for the treatment of certain cancers, including relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma and chronic lymphocytic leukemia.

Original Article: FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

NEXT ARTICLE

More From BioPortfolio on "FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...